Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3183864 | 1.00 | ALOX15 (0.53) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL11209137 | 0.82 | ALOX15 (0.52) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL1491220 | 0.81 | ALOX15 (0.50) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL11030935 | 0.81 | ALOX15 (0.50) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL7531879 | 0.81 | ALOX15 (0.50) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL28237230 | 0.81 | ALOX15 (0.64) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL5604473 | 0.79 | ALOX15 (0.57) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL5604676 | 0.79 | ALOX15 (0.57) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL5604407 | 0.79 | ALOX15 (0.57) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL5604557 | 0.79 | ALOX15 (0.57) | ALOX15ALDH1A1TSHRUSP2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| CN-118252966-A | High-crosslinking amphiphilic embolic microsphere and preparation method thereof | 至微(深圳)医学科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS, PBC | 2025-10-09 | — | — | US | disclosed |
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| WO-2002089862-A2 | AIR FRESHENING COMPOSITIONS, ARTICLES COMPRISING SAME AND METHODS FOR PREPARING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | disclosed |
| EP-0602573-B1 | Process for the preparation of acetals | BASF AG (DE) | 1996-06-12 | — | — | EP | disclosed |
| EP-0371347-B1 | Cyclic ethers and their use as perfuming or flavouring ingredients | FIRMENICH & CIE (CH) | 1995-02-01 | — | — | EP | disclosed |
| EP-0602573-A1 | Process for the preparation of acetals | BASF Aktiengesellschaft (DE) | 1994-06-22 | — | — | EP | disclosed |
| US-5068362-A | Ethoxy-1-methylethyl oxepane | FIRMENICH SA (CH) | 1991-11-26 | — | — | US | disclosed |
| US-5021402-A | 2-(3-methyl-1,3-butadienyl), 4-methyl-2,3,6,7-tetrahydro-or hexahydrooxepin or the 2-(1-ethoxy-1-methyl elkyl derivative; fruity | FIRMENICH SA (CH) | 1991-06-04 | — | — | US | disclosed |
| EP-0371347-A2 | Cyclic ethers and their use as perfuming or flavouring ingredients | FIRMENICH SA (CH) | 1990-06-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CYP8B1, CYP1B1, BBOX1 | ALOX15 25/4885ALDH1A1 117/4885TSHR 4274/4885 |
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | BBOX1, NISCH, TAS2R4 | ALOX15 481/4885ALDH1A1 186/4885TSHR 4188/4885 |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | ALOX15 1962/4885ALDH1A1 868/4885TSHR 2405/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | ALOX15 114/4885ALDH1A1 697/4885TSHR 1822/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | ALOX15 270/4885ALDH1A1 804/4885TSHR 1119/4885 |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | TAS1R3, TAS2R5, TRPA1 | ALOX15 51/4885ALDH1A1 117/4885TSHR 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.